These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9717118)

  • 101. Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation.
    Lindheim SR; Barad DH; Witt B; Ditkoff E; Sauer MV
    J Assist Reprod Genet; 1996 Oct; 13(9):745-7. PubMed ID: 8947826
    [TBL] [Abstract][Full Text] [Related]  

  • 102. [Which stimulation for poor responders? Critical study of results and methods of research].
    Antoine JM
    Contracept Fertil Sex; 1996 May; 24(5):386-90. PubMed ID: 8704818
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders.
    Padilla SL; Dugan K; Maruschak V; Shalika S; Smith RD
    Fertil Steril; 1996 Apr; 65(4):796-9. PubMed ID: 8654641
    [TBL] [Abstract][Full Text] [Related]  

  • 104. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome.
    Land JA; Yarmolinskaya MI; Dumoulin JC; Evers JL
    Fertil Steril; 1996 May; 65(5):961-5. PubMed ID: 8612857
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study.
    van Hooff MH; Alberda AT; Huisman GJ; Zeilmaker GH; Leerentveld RA
    Hum Reprod; 1993 Mar; 8(3):369-73. PubMed ID: 8473450
    [TBL] [Abstract][Full Text] [Related]  

  • 106. High dosages of gonadotropins are associated with poor pregnancy outcomes after in vitro fertilization-embryo transfer.
    Stadtmauer L; Ditkoff EC; Session D; Kelly A
    Fertil Steril; 1994 Jun; 61(6):1058-64. PubMed ID: 8194617
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The value of increasing the dose of human menopausal gonadotropins in women who initially demonstrate a poor response.
    Manzi DL; Thornton KL; Scott LB; Nulsen JC
    Fertil Steril; 1994 Aug; 62(2):251-6. PubMed ID: 8034068
    [TBL] [Abstract][Full Text] [Related]  

  • 108. High doses of gonadotropins have no detrimental effect on in vitro fertilization outcome in normal responders.
    Simon T; Oehninger S; Toner J; Jones D; Muasher S
    Fertil Steril; 1995 Jun; 63(6):1333-6. PubMed ID: 7750610
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Flexible regression models with cubic splines.
    Durrleman S; Simon R
    Stat Med; 1989 May; 8(5):551-61. PubMed ID: 2657958
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Prevention of multiple pregnancies in gonadotropin-insemination cycles.
    Dahdouh EM; Zreik TG; Ghaname W; Garcia-Velasco JA; Balayla J
    Curr Opin Obstet Gynecol; 2022 Jun; 34(3):101-106. PubMed ID: 35645007
    [TBL] [Abstract][Full Text] [Related]  

  • 111. The need to step up the gonadotropin dosage in the stimulation phase of IVF treatment predicts a poor outcome.
    Hock DL; Louie H; Shelden RM; Ananth CV; Kemmann E
    J Assist Reprod Genet; 1998 Aug; 15(7):427-30. PubMed ID: 9717118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 6.